Addressing Inequities in CAD/PAD Care: A Call to Action and a Way Forward, Episode 1 (2024)

Release Date: September 30, 2022
Expiration Date: September 30, 2023
Time to Complete Activity: 0.5 hour
*This activity expired for credit on September 30, 2023 and is no longer available for credit

Faculty
Joshua A. Beckman, MD, MS
Professor of Medicine
Director, Vascular Medicine
Vanderbilt University Medical Center
Nashville, TN

Foluso Fakorede, MD
Interventional Cardiologist
Chief Executive Officer
Fusion Vascular Center
Cardiovascular Solutions of Central Mississippi
Cleveland, MS

Target Audience
This activity has been designed for general cardiologists, interventional cardiologists, vascular surgeons, hospitalists, primary care providers, podiatrists, endocrinologists, nurse practitioners, PAs, and other clinicians who are interested in the diagnosis and management of patients with coronary artery disease (CAD) and/or peripheral artery disease (PAD).
This activity is provided by Paradigm Medical Communications, LLC.

In collaboration with the Association of Black Cardiologists (ABC).

Supporter Acknowledgment
This activity is supported by an educational grant from Janssen Pharmaceuticals, Inc, administered by Janssen Scientific Affairs, LLC.

Program Overview
What increases the odds of “winning” the lower limb amputation lottery? Being Black in America. What lowers the odds? Earlier diagnosis and treatment of peripheral artery disease—the most prevalent, costly, and deadly disease most Americans have never heard of—and coronary artery disease, a common comorbidity. In part 1 of this 2-episode news broadcast, renowned vascular experts delve into the latest research and provide practical, cutting-edge strategies for saving lives and limbs in underserved Black communities, with a focus on diagnosis.

Learning Objectives
Upon completion of this activity, participants should be able to:

A certificate of participation will be available for download/printing immediately following your successful completion of the postassessment and evaluation.

For questions regarding CME credit, contact the Paradigm CME Department at cme@paradigmmc.com.

There are no fees for participating in this activity.

Disclosure of Relevant Financial Relationships
In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Paradigm requires that all planners, faculty, and others who are in a position to control the content of this activity disclose all financial relationships with ineligible companies during the past 24 months.

All relevant relationships are identified and mitigated according to Paradigm policy prior to individuals assuming their roles, and are disclosed prior to learners’ engagement in the activity. Paradigm is committed to providing learners with high-quality accredited continuing education that promotes improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The content of this activity was independently reviewed to ensure that it is fair and balanced, scientifically rigorous, evidence based, and aligned with the public interest. All relevant relationships have been mitigated.

Joshua A. Beckman, MD, MS
Consultant: JanOne Inc; Janssen Pharmaceuticals, Inc; Novartis AG
Research Funding: Bristol-Myers Squibb Company
Other/Investor: Jana Care Inc.

Foluso Fakorede, MD
Has no relevant financial relationships with ineligible companies to disclose.

Paradigm Medical Communications, LLC staff members have no relevant financial relationships with ineligible companies to disclose.

Association of Black Cardiologists, Inc. staff members have no relevant financial relationships with ineligible companies to disclose.

Independent peer reviewer has no relevant financial relationships with ineligible companies to disclose.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.

Disclaimer
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsem*nt of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.

As an ACCME-accredited provider, Paradigm Medical Communications, LLC must ensure that its activities include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsem*nt of specific products by Paradigm Medical Communications, LLC.

Terms of Use and Privacy Policy

Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.

Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.

© 2022 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.